Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016
With the advent of new disease-modifying drugs, the treatment of multiple sclerosis is becoming increasingly complex. Using consensus statements is therefore advisable. The present consensus statement, which was drawn up by the Spanish Society of Neurology's study group for demyelinating diseas...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier España
2017-03-01
|
| Series: | Neurología (English Edition) |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580817300366 |
| _version_ | 1828525277944217600 |
|---|---|
| author | A. García Merino J.R. Ara Callizo O. Fernández Fernández L. Landete Pascual E. Moral Torres A. Rodríguez-Antigüedad Zarrantz |
| author_facet | A. García Merino J.R. Ara Callizo O. Fernández Fernández L. Landete Pascual E. Moral Torres A. Rodríguez-Antigüedad Zarrantz |
| author_sort | A. García Merino |
| collection | DOAJ |
| description | With the advent of new disease-modifying drugs, the treatment of multiple sclerosis is becoming increasingly complex. Using consensus statements is therefore advisable. The present consensus statement, which was drawn up by the Spanish Society of Neurology's study group for demyelinating diseases, updates previous consensus statements on the disease.The present study lists the medications currently approved for multiple sclerosis and their official indications, and analyses such treatment-related aspects as activity, early treatment, maintenance, follow-up, treatment failure, changes in medication, and special therapeutic situations.This consensus statement includes treatment recommendations for a wide range of demyelinating diseases, from isolated demyelinating syndromes to the different forms of multiple sclerosis, as well as recommendations for initial therapy and changes in drug medication, and additional comments on induction and combined therapy and practical aspects of the use of these drugs. Resumen: La incorporación de nuevos medicamentos para modificar el curso de la esclerosis múltiple y la complejidad de su uso plantea la conveniencia de utilizar consensos terapéuticos. El consenso actual ha sido elaborado por el grupo de enfermedades desmielinizantes de la Sociedad Española de Neurología y actualiza consensos previamente publicados.Se enumeran los medicamentos aprobados para la esclerosis múltiple con sus indicaciones oficiales. Se analizan aspectos relacionados con el tratamiento, como la presencia de actividad, la precocidad, el mantenimiento terapéutico, el seguimiento, el fallo terapéutico, los cambios de medicación y el tratamiento en situaciones especiales.Se elaboran indicaciones de tratamiento desde el síndrome desmielinizante aislado a las distintas formas de esclerosis múltiple detallando recomendaciones de tratamiento inicial, cambios de medicación, con consideraciones sobre terapia combinada e inducción y aspectos prácticos del uso de medicamentos. Keywords: Multiple sclerosis, Consensus statement, Disease-modifying drugs, Lines of therapy, Changes in medication, Algorithm, Palabras clave: Esclerosis múltiple, Consenso, Medicamentos para el curso de la enfermedad, Líneas terapéuticas, Cambios de medicación, Algoritmo |
| first_indexed | 2024-12-11T21:04:08Z |
| format | Article |
| id | doaj.art-547de10ad65641e6a7df65d7f9f9d974 |
| institution | Directory Open Access Journal |
| issn | 2173-5808 |
| language | English |
| last_indexed | 2024-12-11T21:04:08Z |
| publishDate | 2017-03-01 |
| publisher | Elsevier España |
| record_format | Article |
| series | Neurología (English Edition) |
| spelling | doaj.art-547de10ad65641e6a7df65d7f9f9d9742022-12-22T00:50:55ZengElsevier EspañaNeurología (English Edition)2173-58082017-03-01322113119Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016A. García Merino0J.R. Ara Callizo1O. Fernández Fernández2L. Landete Pascual3E. Moral Torres4A. Rodríguez-Antigüedad Zarrantz5Hospital Puerta de Hierro, Majadahonda, Madrid, Spain; Corresponding author.Hospital Miguel Servet, Zaragoza, SpainComplejo Hospitalario de Málaga, Málaga, SpainHospital Dr. Peset, Valencia, SpainHospital Moisés Broggi, Sant Joan Despí, Barcelona, SpainHospital de Basurto, Bilbao, Vizcaya, SpainWith the advent of new disease-modifying drugs, the treatment of multiple sclerosis is becoming increasingly complex. Using consensus statements is therefore advisable. The present consensus statement, which was drawn up by the Spanish Society of Neurology's study group for demyelinating diseases, updates previous consensus statements on the disease.The present study lists the medications currently approved for multiple sclerosis and their official indications, and analyses such treatment-related aspects as activity, early treatment, maintenance, follow-up, treatment failure, changes in medication, and special therapeutic situations.This consensus statement includes treatment recommendations for a wide range of demyelinating diseases, from isolated demyelinating syndromes to the different forms of multiple sclerosis, as well as recommendations for initial therapy and changes in drug medication, and additional comments on induction and combined therapy and practical aspects of the use of these drugs. Resumen: La incorporación de nuevos medicamentos para modificar el curso de la esclerosis múltiple y la complejidad de su uso plantea la conveniencia de utilizar consensos terapéuticos. El consenso actual ha sido elaborado por el grupo de enfermedades desmielinizantes de la Sociedad Española de Neurología y actualiza consensos previamente publicados.Se enumeran los medicamentos aprobados para la esclerosis múltiple con sus indicaciones oficiales. Se analizan aspectos relacionados con el tratamiento, como la presencia de actividad, la precocidad, el mantenimiento terapéutico, el seguimiento, el fallo terapéutico, los cambios de medicación y el tratamiento en situaciones especiales.Se elaboran indicaciones de tratamiento desde el síndrome desmielinizante aislado a las distintas formas de esclerosis múltiple detallando recomendaciones de tratamiento inicial, cambios de medicación, con consideraciones sobre terapia combinada e inducción y aspectos prácticos del uso de medicamentos. Keywords: Multiple sclerosis, Consensus statement, Disease-modifying drugs, Lines of therapy, Changes in medication, Algorithm, Palabras clave: Esclerosis múltiple, Consenso, Medicamentos para el curso de la enfermedad, Líneas terapéuticas, Cambios de medicación, Algoritmohttp://www.sciencedirect.com/science/article/pii/S2173580817300366 |
| spellingShingle | A. García Merino J.R. Ara Callizo O. Fernández Fernández L. Landete Pascual E. Moral Torres A. Rodríguez-Antigüedad Zarrantz Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016 Neurología (English Edition) |
| title | Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016 |
| title_full | Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016 |
| title_fullStr | Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016 |
| title_full_unstemmed | Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016 |
| title_short | Consensus statement on the treatment of multiple sclerosis by the Spanish Society of Neurology in 2016 |
| title_sort | consensus statement on the treatment of multiple sclerosis by the spanish society of neurology in 2016 |
| url | http://www.sciencedirect.com/science/article/pii/S2173580817300366 |
| work_keys_str_mv | AT agarciamerino consensusstatementonthetreatmentofmultiplesclerosisbythespanishsocietyofneurologyin2016 AT jraracallizo consensusstatementonthetreatmentofmultiplesclerosisbythespanishsocietyofneurologyin2016 AT ofernandezfernandez consensusstatementonthetreatmentofmultiplesclerosisbythespanishsocietyofneurologyin2016 AT llandetepascual consensusstatementonthetreatmentofmultiplesclerosisbythespanishsocietyofneurologyin2016 AT emoraltorres consensusstatementonthetreatmentofmultiplesclerosisbythespanishsocietyofneurologyin2016 AT arodriguezantiguedadzarrantz consensusstatementonthetreatmentofmultiplesclerosisbythespanishsocietyofneurologyin2016 |